Suchergebnisse - "Velez Torres, Jaylou M"

PubPharm (42)

1

Exploring cytologic features and potential diagnostic challenges of metastatic NUT carcinoma to the parotid gland : A case report and a comprehensive literature review

enthalten in: Diagnostic cytopathology | 2024

von Li, C. | Salihoglu, S. | Civantos, F. | +1

2

Atypia of Undetermined Significance and ThyroSeq v3 Positive Call Rates as Quality Control Metrics for Cytology Laboratory Performance

enthalten in: bioRxiv.org | 2024

von Mejia-Mejia, O. | Bravo-Gonzalez, A. | Sanchez-Avila, M. | +11

3

Exploring the atypia of undetermined significance : Malignant ratio, ThyroSeq v3 positive call rate, molecular-derived risk of malignancy, and risk of malignancy as possible quality metric tools in thyroid cytology

enthalten in: Cancer cytopathology | 2024

von Velez Torres, J. | Curnow, P. | Tjendra, Y. | +5

4

Atypia of undetermined significance and ThyroSeq v3-positive call rates as quality control metrics for cytology laboratory performance

enthalten in: Cancer cytopathology | 2024

von Mejia-Mejia, O. | Bravo-Gonzalez, A. | Sanchez-Avila, M. | +11

5

Spotlight : Rising stars in cytology

enthalten in: Cancer cytopathology | 2024

von Velez Torres, J.

6

Synovial Sarcoma of the Gastrointestinal Tract

enthalten in: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc | 2024

von Ortiz Requena, D. | Longacre, T. | Rosenberg, A. | +5

7

Don't SUMP it! Utility of PLAG1 immunocytochemistry in basaloid SUMP subcategory

enthalten in: Cancer cytopathology | 2024

von Sanchez-Avila, M. | Tjendra, Y. | Zuo, Y. | +5

8

Adjuvant Radiation Therapy for Salivary Duct and Epithelial Myoepithelial Salivary Carcinoma

enthalten in: Practical radiation oncology | 2023

von Freedman, L. | Beadle, B. | Chera, B. | +1

9

TRPS1 immunohistochemical expression in salivary gland tumors : A pilot study

enthalten in: American journal of clinical pathology | 2023

von Tjendra, Y. | Kerr, D. | Gomez-Fernandez, C. | +1

10

Probability of malignancy and molecular alterations as determined by ThyroSeq v3 genomic classifier in Bethesda Category IV

enthalten in: Cancer cytopathology | 2023

von Tjendra, Y. | Kerr, D. | Zuo, Y. | +4

1
2
3
4
5
Nächster »
[5]